Stock LLM Wiki

報告_UBS_智原3035_3Q26_20261027

更新 2026-10-28

PDF 原檔:報告_UBS_智原3035_3Q26_20261027_original.pdf

圖片清單(已驗證 2026-10-28)

檔名 size 分類 親眼所見內容
報告_UBS_智原3035_3Q26_20261027_001.png 51KB 真資料圖 智原股價(NT$)與 NTM P/E 歷史圖,2002-10 至 2026-10,圖內標示平均 P/E 18x、+1 標準差 27x、-1 標準差 10x(財務圖,不嵌 lib)
報告_UBS_智原3035_3Q26_20261027_002.png 46KB 真資料圖 智原股價(NT$,左軸)與外資(QFII)持股比重(%,右軸)疊圖,2008 至 2026,來源 TEJ;持股比重 2021 前後高點約 36–38%、2025 年低點約 6–8%、2026 年回升至約 20%(財務圖,不嵌 lib)
報告_UBS_智原3035_3Q26_20261027_003.png 64KB 真資料圖 UBS 目標價(NT$)階梯線與股價疊圖,2023-08 至 2026-10,下方標示評等區間(Buy/Neutral/Sell/No Rating)(財務圖,不嵌 lib)

校正紀錄

  • 2026-10-28:本頁 ## 原始內容 由 docling 解析,文字層遺失部分數字(例:「NT$ .07」「+ % QoQ」「NT$ 90」「3 % QoQ」「12nm」誤為「2nm」等)。以 PyMuPDF 對 _original.pdf 文字層核對後,lib 引用數字以原 PDF 為準:Q326 EPS NT$1.07;Q326 營收 NT$3.66bn(+11% QoQ);NRE -31% QoQ;PT NT$200(前 NT$190);24x 2027E PE(前 22x);2026E EPS(reported)3.43→3.68;2027/28E EPS -4%/-1%;首頁 UBS diluted EPS:26E 3.45→3.66、27E 8.70→8.35、28E 14.07→13.86(共識 3.38/6.29/9.57);2029E 16.54、2030E 18.83;「new UMC 12nm project」「initial contribution from 12nm node」「MP targeted within 1-2 years」「H127」。內文表格內缺位數字同理(如 28E 營收 24,794 正確、2029E 28,815)。原文保留未改動。

原始內容

First Read

Faraday Technology

New opportunities in advanced nodes

Q326 beat on turnkey strength and non-op gains; Q 26 outlook positive

Q326 EPS of NT$ .07 came in above UBS/Street expectations mainly on non-op gains. Q326 sales came in at NT$3.66 bn (+ % QoQ), ahead of its original guidance but in line with its comment during Taiwan Summit with turnkey sales up 20% QoQ given better support from OSAT and foundries, despite NRE declining 3 % QoQ. Q326 GM decreased 2.7ppt QoQ to 42.5% on higher turnkey mix, while OPEX grew 9% QoQ on salary adjustment and higher bonus accrual. Non-op gain of NT$266mn mainly includes valuation gains on an investee company. For Q426F, it guided sales flat QoQ remaining at high levels with IP and NRE up QoQ, and turnkey down QoQ. GM is guided back to ~45%, reflecting normalized ASIC economics; OPEX should decline single digit QoQ.

2027 growth outlook supported by AI, advanced packaging and 12nm node

Management guided for double-digit sales growth in 2027, with all three businesses, IP, NRE and turnkey, expected to grow, driven by three key catalysts: AI, advanced packaging and new UMC 2nm project contribution. For IP, growth should be supported by higher royalties on foundry price hikes/customer capacity expansion and initial contribution from 2nm node; NRE should benefit from 2nm/4nm projects entering peak recognition, with 3-4 ASIC tape-outs targeted in H 27; while MP should see growth in both MCU and ASIC as new projects gradually ramp. AI-related mix was at 8-9% of Q326 sales, and is expected to increase throughout 2027 alongside accelerating advanced-packaging shipments. We expect 2027E sales to grow 37% YoY.

2nm design win opens new advanced-node and product opportunities

Faraday secured a 2nm GAA special purpose ASIC project worth several tens of millions of US dollars in NRE, which management described as its largest-ever design win and most advanced project to date. The project spans front-end design and IP integration, back-end design, customized 3D DRAM and advanced packaging, and marks Faraday's first customized 3D DRAM and hybrid-bonding project. It expects to recognize its first NRE milestone in H 27, followed by MP targeted within -2 years. Beyond 2nm, Faraday is expanding into new applications including OCS, CXL and Si-cap, leveraging its capabilities in advanced packaging, interposer design and ASIC integration. We believe successful execution by Faraday and its foundry partner could strengthen Faraday's positioning in advanced-node projects and create follow-on design-win opportunities.

Valuation: Raise PT to NT$200, stay Neutral

We raise 2026E EPS (reported) from NT$3.43 to NT$3.68 on better Q326, but lower 2027/28E EPS by 4%/ % to factor in softer CE demand and higher OPEX. We raise our PT to NT$200 from NT$ 90 using 24x 2027E PE (vs prior 22x). We raise our multiple as the recent 2nm project win should boost investor confidence, but stay Neutral as the advanced nodes (4nm/2nm) turnkey revenue recognition depends on the foundry partner's execution. We await clearer evidence before revisiting our assumptions.

Highlights (NT$m) 12/23 12/2 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
Revenues ,966 ,065 7,993 3,438 8,356 24,794 28,8 5 32,737
EBIT (UBS) ,956 ,07 552 ,035 3,023 4,85 5,744 6,494
Net earnings (UBS) ,589 ,04 73 953 2, 76 3,6 2 4,309 4,907
EPS (UBS, diluted) (NT$) 6.39 4.05 2.8 3.66 8.35 3.86 6.54 8.83
DPS (net) (NT$) 0.00 4.29 3.00 .80 2.02 5.0 9.0 0.75
Net (debt) / cash 5,445 7,863 6,677 8,054 9,326 0,899 2,685 4,5 4
Profitability/valuation 12/23 12/2 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
EBIT (UBS) margin % 6.3 9.7 3. 7.7 6.5 9.6 9.9 9.8
ROIC (EBIT) % 43.9 2 .4 8.9 2.2 29.5 44.9 5 .0 56.6
EV/EBITDA (UBS core) x 24.5 38.4 28. 2 .6 0.5 7.0 5.8 5.0
P/E (UBS, diluted) x 40.8 75.2 66.3 52.3 22.9 3.8 .6 0.2
Equity FCF (UBS) yield % 3.6 2.4 0.5 3.3 5. 7.3 9.8 0.8
Dividend yield (net) % 0.0 .4 .6 0.9 . 2.6 4.7 5.6

Source: Company accounts, LSEG Eikon, UBS estimates. Metrics marked as (UBS) have had analyst adjustments applied. Valuations: based on an average share price that year, (E): based on a share price of NT$ 9 .50 on 27-Oct-2026

Equities

Taiwan

Semiconductors

12-month rating Neutral
12m price target NT$200.00
Prior : NT$190.00
Price (27 Oct 2026) NT$191.50

RIC: 3035.TWBBG: 3035 TT

Trading data and key metrics

52-wk range NT$233.00- 39.00
Market cap. NT$49.9b/US$ .54b
Shares o/s 26 m (ORD)
Free float 86%
Avg. daily volume ('000) 4,502
Avg. daily value (m) NT$832
Common s/h equity (12/26E) NT$ 7.3b
P/BV (12/26E) 2.9x
Net debt to EBITDA (12/26E) NM
EPS (UBS, diluted) (TWD) From To % ch Cons.
12/26E 3.45 3.66 6 3.38
12/27E 8.70 8.35 -4 6.29
12/28E 4.07 3.86 - 9.57

Jerry Su

Analyst jerry.su@ubs.com +886-28-722 7306

Annie Chen

Associate Analyst annie.chen@ubs.com +886-2-8722 728

Figure 1: UBS vs. VA Consensus 3Q26A/ Q26E and 2025A-28E

(NT$m) 2Q26 - Actual 3Q26 - Actual 3Q26 - UBSe prior 3Q26 - VA 4Q26E - UBSe 4Q26E - UBSe prior 4Q26E - VA 2025 2025 - Actual 2026E - UBSe 2026E - UBSe prior 2026E - VA 2027E - UBSe 2027E - UBSe prior 2027E - VA 2028E - UBSe 2028E - UBSe prior 2028E - VA
Revenue 3,314 3,664 3,081 3,172 3,871 3,442 4,006 17,993 13,438 12,425 13,080 18,356 19,135 17,299 24,794 25,593 20,504
- QoQ / YoY 28.0% 10.6% -7.0% -4.3% 5.7% 11.7% 26.3% 62.6% -25.3% -30.9% -27.3% 36.6% 54.0% 32.3% 35.1% 106.0% 18.5%
Gross profit 1,499 1,557 1,400 1,434 1,730 1,545 1,751 4,857 6,010 5,668 5,908 7,999 7,945 7,413 9,999 10,129 8,555
- Gross margin 45.2% 42.5% 45.4% 45.2% 44.7% 44.9% 43.7% 27.0% 44.7% 45.6% 45.2% 43.6% 41.5% 42.9% 40.3% 39.6% 41.7%
Operating profit 271 214 211 230 460 468 609 552 1,041 1,045 1,206 3,023 3,129 2,393 4,851 4,901 3,026
- OP margin 8.2% 5.8% 6.8% 7.2% 11.9% 13.6% 15.2% 3.1% 7.7% 8.4% 9.2% 16.5% 16.4% 13.8% 19.6% 19.1% 14.8%
Non-Op 111 265 123 94 119 122 100 449 578 439 388 311 301 341 340 340 356
Pre-tax profit 382 482 333 323 579 590 709 1,002 1,622 1,487 1,594 3,334 3,430 2,734 5,191 5,241 3,382
Tax 96 111 73 73 127 130 160 229 379 343 374 734 755 618 1,142 1,153 779
- Tax rate -25% -23% -22% -23% -22% -22% -23% -23% -23% -23% -23% -22% -22% -23% -22% -22% -23%
Net profit 198 279 188 216 378 403 496 731 959 893 1,014 2,176 2,266 1,914 3,612 3,666 2,351
EPS (NT$) 0.76 1.07 0.72 0.87 1.45 1.55 1.72 2.81 3.68 3.43 3.76 8.35 8.70 7.00 13.86 14.07 9.02

Source: UBS estimates, Visible Alpha. Note: EPS in this table is reported, which may differ from UBS adjusted EPS as shown in the tables on the front page.

Figure 2: Faraday annual P&L summary

Ticker Shares outstanding (mn) - Year 2025 3035.TWCurrent 260.5 - 2026E Price (NT$) Mkt cap (NT$ mn) - 2027E Price (NT$) Mkt cap (NT$ mn) - 2028E 2029E $191.5 $49,895 - 2030E
Revenues (NT$ mn) $17,993 $13,438 $18,356 $24,794 $28,815 $32,737
YoY Growth (%) -25.3% 36.6% 35.1% 16.2% 13.6%
Gross profit (NT$mn) $4,857 $6,010 $7,999 $9,999 $11,192 $12,395
GM (%) 27.0% 44.7% 43.6% 40.3% 38.8% 37.9%
Operating profit (NT$mn) $552 $1,041 $3,023 $4,851 $5,744 $6,494
OPM (%) 3.1% 7.7% 16.5% 19.6% 19.9% 19.8%
Net profit (NT$ mn) $731 $959 $2,176 $3,612 $4,309 $4,907
EPS (NT$) $2.81 $3.68 $8.35 $13.86 $16.54 $18.83
EPS growth (%) 31.1% 126.9% 66.0% 19.3% 13.9%
P/E (x) 68.2 52.0 22.9 13.8 11.6 10.2
Dividend yield (%) 1.6% 0.9% 1.1% 2.6% 4.7% 5.6%
P/B (x) 3.8 2.9 2.6 2.3 2.1 2.0
ROE (%) 5.6% 5.5% 11.5% 17.0% 18.6% 19.4%

Source: UBS estimates, company data. Note: EPS in this table is reported, which may differ from UBS adjusted EPS as shown in the tables on the front page.

Figure 3: Faraday annual and quarterly forecast summary

Quarters 1Q25 2Q25 3Q25 4Q25 1Q26 2Q26 3Q26E 4Q26E
Revenues (NT$ mn) $7,438 $4,512 $3,236 $2,808 $2,589 $3,314 $3,664 $3,871
-- QoQ Growth (%) 151.9% -39.3% -28.3% -13.2% -7.8% 28.0% 10.6% 5.7%
-- YoY Growth (%) 188.4% 70.3% 12.2% -4.9% -65.2% -26.6% 13.2% 37.9%
Gross profit $1,508 $1,091 $1,075 $1,184 $1,224 $1,499 $1,557 $1,730
-- Gross Margin (%) 20.3% 24.2% 33.2% 42.2% 47.3% 45.2% 42.5% 44.7%
Operating Profit $369 $64 $39 $80 $96 $271 $214 $460
-- OP Margin (%) 5.0% 1.4% 1.2% 2.9% 3.7% 8.2% 5.8% 11.9%
Non-op $86 ($19) $173 $209 $83 $111 $265 $119
Pre-tax profit (NT$ mn) $455 $45 $213 $290 $179 $382 $482 $579
Tax $103 $9 $48 $68 $44 $96 $111 $127
-- tax rate (%) 22.7% 21.2% 22.6% 23.5% 24.6% 25.2% 23.0% 22.0%
Net profit (NT$ mn) $346 $26 $152 $208 $104 $198 $279 $378
-- QoQ Growth (%) 46.6% -92.5% 487.3% 36.8% -49.8% 89.9% 40.8% 35.5%
-- YoY Growth (%) 23.5% -90.1% -42.5% -12.1% -69.9% 666.4% 83.8% 82.1%
EPS (NT$) $1.33 $0.10 $0.58 $0.80 $0.40 $0.76 $1.07 $1.45

2024

2025

2026E

2027E

2028E

$11,065 $17,993 $13,438 $18,356 $24,794

188.4% 70.3% 12.2% -4.9% -65.2% -26.6% 13.2% 37.9% -7.5% 62.6% -25.3% 36.6% 35.1%

$5,051 $4,857 $6,010 $7,999 $9,999

20.3% 24.2% 33.2% 42.2% 47.3% 45.2% 42.5% 44.7% 45.7% 27.0% 44.7% 43.6% 40.3%

$1,071

$552

$1,041 $3,023 $4,851

5.0% 1.4% 1.2% 2.9% 3.7% 8.2% 5.8% 11.9% 9.7% 3.1% 7.7% 16.5% 19.6%

$272

$449

$578

$311

$340

$1,343 $1,002 $1,622 $3,334 $5,191

$271

$229

$379

$734

$1,142

22.7% 21.2% 22.6% 23.5% 24.6% 25.2% 23.0% 22.0% 20.2% 22.8% 23.3% 22.0% 22.0%

$1,041

$731

$959

$2,176 $3,612

23.5% -90.1% -42.5% -12.1% -69.9% 666.4% 83.8% 82.1% -34.5% -29.8% 31.1% 126.9% 66.0%

$4.05

$2.81

$3.68

$8.35

$13.86

Source: UBS estimates, company data. Note: EPS in this table is reported, which may differ from UBS adjusted EPS as shown in the tables on the front page.

Figure : Faraday historical P/E range

Source: LSEG

Figure 5: Faraday FINI holding

Source: TEJ

Forecast returns

Forecast price appreciation 4.4%
Forecast dividend yield 0.9%
Forecast stock return 5.4%
Market return assu ption 6.3%
Forecast excess return -1.0%

Company Description

Faraday was founded in 993, spun off from UMC's IP and semiconductor design service department as the first IC design service company in Asia. It is an IC design and production service provider that initially focused on specialty applications on mature nodes by partnering with UMC and gradually upgraded to advanced nodes through working with Samsung. The company had its IPO on the Taiwan Securities Exchange in 999.

Valuation Method and Risk Statement

We value Faraday using PE methodology.

Downside risks include slower-than-expected advanced nodes migration, further delay of advanced packaging ramp, and growing competition in specialty projects from China IC design service companies.

Quantitative Research Review

UBS Global Research publishes a quantitative assessment of its analysts' responses to certain questions about the likelihood of an occurrence of a number of short term factors in a product known as the 'Quantitative Research Review'. The views for this month can be found below. Views contained in this assessment on a particular stock reflect only the views on those short term factors which are a different timeframe to the 2-month timeframe reflected in any equity rating set out in this note. For previous responses please make reference to (i) previous UBS Global Research reports; and (ii) where no applicable research report was published that month, the Quantitative Research Review which can be found at https://neo.ubs.com/quantitative, or contact your UBS sales representative for access to the report or the Quantitative Research Team on ubs-quant-answers@ubs.com. A consolidated report which contains all responses is also available and again you should contact your UBS sales representative for details and pricing or the Quantitative Research Team on the email above.

Faraday Technology

Question Response
1. Is the industry structure facing the fir likely to i prove or deteriorate over the next six onths? Rate on a scale of 1-5 (1 = getting worse, 3 = no change, 5 = getting better, N/A = no view) 3
2. Is the regulatory/govern ent environ ent facing the fir likely to i prove or deteriorate over the next six onths? Rate on a scale of 1-5 (1 = getting tougher 3 = no change, 5 = getting better, N/A = no view) 3
3. Over the last 3-6 onths in broad ter s have things been i proving/no change/getting worse for this stock? Rate on a scale of 1-5 (1 = getting a lot worse, 3 = not uch change, 5 = getting a lot better, N/A = no view) 4
4. Relative to the current CONSENSUS EPS forecast, is the next co pany EPS update likely to lead to: (1 = negative surprise vs consensus, 3 = in-line with consensus, 5 = positive surprise vs consensus expectations, N/A = no view) 3
5. What's driving the difference?
6. Relative to YOUR current earnings forecast, is there relatively greater risk at the next earnings result of:(1 = downside skew risk to earnings, 3 = equal upside or downside risk to earnings, 5 = upside skew risk to earnings, N/A = no view) 3
7. What's driving the difference?
8. Is there an upco ing catalyst for the co pany over the next three onths?
9. Is there an actual or approxi ate date for the catalyst?
10. Is the catalyst date an actual or approxi ate date?
11. What is the catalyst?